why advertise in the lancet?

The Lancet is the world’s leading independent general medical journal

and has been published weekly since 1823. The journal has an international scope

and its coverage extends across all aspects of human health.

Only ground-breaking, original, primary research papers, and review articles

of the highest standard make it through The Lancet’s stringent peer-review

process. This ensures the continuing scientific merit and clinical relevance of its

diverse content.

This blend of challenging editorials, signed commentaries, original research,

commissioned reviews, international news, and the views of readers in the

letters pages make The Lancet an essential weekly read for physicians all over

the world.

The Lancet has a dedicated career opportunities section as well as web

advertising, sponsorship opportunities and review journals which focus on

specific therapy areas such as oncology, neurology and infectious diseases.

Our readers are the most influential physicians in the world and, with an average

subscription duration of over 17 years, it is clear that The Lancet commands trust

and respect from our readers in the worldwide medical community.

display advertising rates

one insertion region cost

double page spread uk only £2,430

four colour row £2,673

usa £4,689

global £10,800

full page uk only £1,350

four colour row £1,485

usa £2,605

global £6,000

half page uk only £888

Colour row £968

usa £1,675

global £3,825

full page uk only £935

mono row £1,030

usa £1,775

global £4,100

special positions

outside back cover +30%

inside front cover +20%

inside back cover +10%

series discounts

3–6 insertions 4%

7–11 insertions 8%

12+ insertions POA

agency discount 10%

advertisement deadline: 10 days prior to cover date. The Lancet is

published every Saturday.

All bookings are subject to The Lancet conditons of acceptance.

about our readers

reader profile

• 90% of subscribers trust The Lancet to keep them informed of changes in world medicine

• Our average subscription length is 17 years

• 69% influence the purchase of medical equipment in their workplace

• 88% of subscribers are medically qualified

• 82% are hands-on clinicians

• 65% attend up to 7 conferences per year 60% as a result of The Lancet’s Conference listing

• Over half of The Lancet’s readers have acted as a result of an advertisement

• 76% of subscribers use The Lancet for career opportunities

the lancet profile – from subscriber survey

qualified circulation by region

circulation 29,103 circulation statement: December bpa 2007

Split runs available on request

1,2 publishers statement

The Lancet’s Global Reach

Print Edition

Registered users on thelancet.com

contact

For further information, bookings and to send artwork, please contact:

Sarah Jane Cahill Business Development Executive

Tel +44 (0) 20 7424 4538 Fax +44 (0) 20 7424 4433 Email sarah.cahill@lancet.com

Martin Sibson

Tel +44 (0) 20 7424 4963 Fax +44 (0) 20 7424 4433 Email m.sibson@elsevier.com

• Over 1.8 million registered users worldwide on www.thelancet.com1

• Over 83,000 E-ToC subscribers (weekly)2

reprints and e-prints

Do you need to share important information with your clients?

The Lancet reprints service offers you the answer — providing a full reprint of

any original article appearing in The Lancet, or it’s sister publications, which you

can hand to your clients, salesforce or shareholders.

Add authority to your existing product literature and help to establish and

develop your market position.

Full reprint service provided:

• Guaranteed integrity of information through The Lancet branding, full

bibliographic details including all references, and the high-quality printing

and finish you find in the weekly journal

• Standard printing up to 10 working days — Express printing available —

maximum of 3 working days

• Opportunity to feature your company logo on the front or cover

• Translation into any language

• Minimum order of 100, with no maximum — volume discounts mean

the more you order the more cost effective it becomes

• Combined reprints — a selection of The Lancet papers of your choice in one

handy document

• E-prints service also available — providing you with a PDF file you can

place on your own website, or for distribution

E-prints

The Lancet E-prints can be posted on your website and accessed by chosen

clients on a password basis providing fast, easy access to information.

contact

For further information on The Lancet reprint and e-print service, please contact:

John Fyfe Business Development Executive

Tel +44 (0) 20 7424 4329 Fax +44 (0) 20 7424 4433 Email j.fyfe@Elsevier.com

sponsorship opportunities

Sponsored subscriptions to The Lancet provide a unique opportunity to

keep your target groups of clinicians updated on international medical

news and research, while promoting your current products.

Sponsored subscriptions are delivered direct to the chosen recipient on

your behalf and they provide you with exclusive promotional opportunities.

Sponsored subscriptions are available for all four journals at specially

discounted rates.

Commissioned research studies* carried out amongst physicians in receipt of a

sponsored complimentary subscription to The Lancet found that:

1 Nine out of ten receivers of The Lancet found the complimentary subscription

valuable to their practice and wished to continue receiving it.

2 Three quarters of all respondents were aware that their subscription to The

Lancet was sponsored by a pharmaceutical company. Moreover, one half also

recalled, on an unaided basis, the name of the sponsoring company.

3 Six out of ten participants remembered unaided that the cover wrap

on their issue of The Lancet displayed an advertisement for ‘Product A’.

4 97.3% of the physicians who recalled seeing ‘Product A’ on the cover wrap,

were aware of its uses and indications prior to receiving complimentary

subscription.

5 One third of the physicians who recalled seeing ‘Product A’ took one or more

favourable actions towards ‘Product A’ in response to reading its message.

These actions included prescribing the product, discussing it with a product

representative or colleague and seeking more information about the product.

*from subscription evaluation study, nov 2003, conducted by matalia group, inc.

contact

For further information, please contact:

Sarah Cahill

Tel +44 (0) 207 424 4538 Fax +44 (0)207 424 4538 Email s.cahill@elsevier.com

display advertising specifications

digital specifications

• Our preferred method of supply is as a PDF created using Acrobat Distiller Version 5.0.

• PDF files to be supplied as composite CMYK.

• Files must be supplied as single pages.

• Pages must be created to include bleed when required.

• Crop marks must be outside the bleed area. A 3mm offset is recommended.

• Files must contain all images in high-resolution, CMYK format and have all fonts embedded.

flightchecking

• All files must be run through an agreed flight-checking application before transmission, to ensure file and colour integrity. (The flightchecker must ensure the following: Acrobat 3.0 compatibility. Image resolution 300 dpi (min). All fonts embedded. Colour is CMYK).

• Content of digital files must be verified fore transmission and all relevant graphics and fonts must be included. The file content remains the responsibility of the sender

supplying files

• If supplying files on disc, please use industry standard CD-ROM. Media must be write - protected and contain only the file required

for each advertisement.

• If a disc is being supplied it should be clearly labelled with identification information indicating client, headline, journal, issue and originator’s details.

• Files may be transmitted via ISDN, with prior arrangement: +44 (0)20 7831 0389.

• An email confirming the sending of any digital advert should be sent prior to transmission and should contain the identification information as specified.

hard copy proofs

• All digital files submitted must be accompanied by a proof. We require 100% of final size, customer approved colour contract proofs.

• Acceptable proofs are: Fuji First Proof, Scitex Iris, Imation Rainbow, Kodak Approval, DuPont Digital Cromalin.

• The Lancet cannot accept responsibility for colour reproduction if one of the above colour proofs is not supplied.

Please use URN; LANCET + your booking order ref

mechanical data (all sizes in mm)

size depth width

type area

full page 260 186

double page spread 260 400

trim marks

whole page 282 210

double page spread 282 420

bleed

whole page 292 220

double page spread 292 430

Advertising copy must be supplied digitally to the specifications below.

contact

For further information, bookings and to send artwork, please contact:

Sarah Jane Cahill Business Development Executive

Tel +44 (0) 20 7424 4538 Fax +44 (0) 20 7424 4433 Email sarah.cahill@lancet.com

or

Martin Sibson

Business Development Executive

Tel +44 (0) 20 7424 4963 Fax +44 (0) 20 7424 4433 Email m.sibson@elsevier.com

terms and conditions

• Advertising orders are subject to written confirmation and will only be accepted

on condition that the advertiser warrants that the advertisements supplied do

not contravene the Trade Description Act 1968, the Race Relations Act 1968 or

the ABPI Code of Practice/FDA Guidelines.

• Accounts are strictly net and are subject to satisfactory reference.

• All invoices must be settled within 30 days of receipt.

• All copy is subject to the approval of the publishers. The publishers reserve the right to

reject any advertisement not of direct interest to the readership or not in keeping with the

scientific and ethical standards of the publication.

• Cancellations must be received in writing no later than six weeks before publication date.

Advertisers failing to comply with these requirements will be liable for payment of the full

space booked.

• If the advertiser cancels part of the series booking, all unearned discounts will be surcharged.

• If the copy instructions have not been received by the stated deadline, existing material

may be repeated and the advertisers will be liable for payment of the full space booked.

• Advertiser’s material is held at the owner’s risk and should be insured by them against fire,

loss or damage. Material will be held for twelve months and then destroyed unless return

is requested.

• The publishers will not be liable for any loss occasioned by the failure of any

advertisement to appear, nor do they accept liability for printer’s errors, although

every care is taken to avoid mistakes.

• All freight and import charges incurred in sending material for publication and all costs

incurred because of failure to comply with mechanical specifications will be charged to the

advertiser.

• The advertiser will indemnify and protect the publishers from any claims or actions

against them arising from unauthorised, inaccurate or libellous statements appearing in

advertising material.

Since its launch in March 2002, The Lancet Neurology has already built an impressive reputation for its outstanding review content, becoming a must-read journal for neurologists. It is this great reputation and high profile which has now allowed The Lancet Neurology to extend its scope to include original primary research for the first time from its October 2005 issue.

However, in addition to publishing the cream of new research in the field, The Lancet Neurology will continue to provide neurology specialists with clear and concise reviews examining the most important recent advances with the greatest and most immediate impact on clinical practice. The Lancet’s global reporting capabilities ensure that The Lancet Neurology provides the most important and current international news from this vast specialty; its two news sections, ‘Newsdesk’ and ‘Media Watch’ ensure that it responds rapidly to international developments in neurology with great precision.

The Lancet Neurology is the first place neurologists look when researching respected opinions, news and reviews or being updated on the latest in clinical trials. It is also the perfect place to advertise your neurology career opportunities and services.

The WebsiteCombining print advertising with electronic advertising opportunities on The Lancet Neurology website provides advertisers with access to a vast new audience. The Lancet Neurology website contains the latest table of contents, abstracts, accepted papers, instructions for authors and more: www.thelancet.com/journals/laneur

display advertising rates

frequency cost

double page spread x1 month £2,005

x3 month £1,856

x6 month £1,790

x12 month £1,485

full page four colour x1 month £1,432

x3 month £1,326

x6 month £1,220

x12 month £1,061

half page four colour x1 month £902

x3 month £835

x6 month £770

x12 month £669

special positions

outside back cover +20%

inside front cover +15%

inside back cover +10%

first right-hand page +10%

discounts

agency discount 10%

circulation

Worldwide – 4,492 BPa DEC 2007

Split runs available on request

The Lancet Neurology is published monthly All bookings are subject to The Lancetconditions of acceptance.

display advertising information

Neurology

display advertising specifications

digital specifications

• Our preferred method of supply is as a PDF created using Acrobat Distiller Version 5.0.

• PDF files to be supplied as composite CMYK.

• Files must be supplied as single pages.

• Pages must be created to include bleed when required.

• Crop marks must be outside the bleed area. A 3mm offset is recommended.

• Files must contain all images in high-resolution, CMYK format and have all fonts embedded.

flightchecking

• All files must be run through an agreed flightchecking application before transmission, to ensure file and colour integrity. (The flightchecker must ensure the following: Acrobat 3.0 compatibility. Image resolution 300 dpi (min). All fonts embedded. Colour is CMYK).

• Content of digital files must be verified before transmission and all relevant graphics and fonts must be included. The file content remains the responsibility of the sender.

supplying files

• If supplying files on disc, please use industry standard CD-ROM. Media must be write - protected and contain only the file required for each advertisement.

• If a disc is being supplied it should be clearly labelled with identification information indicating client, headline, journal, issue and originator’s details.

• Files may be transmitted via ISDN, with prior arrangement: +44 (0)20 7831 0389.

• An email confirming the sending of any digital advert should be sent prior to transmission and should contain the identification information as specified.

hard copy proofs

• All digital files submitted must be accompanied by a proof. We require 100% of final size, customer approved colour contract proofs.

• Acceptable proofs are: Fuji First Proof, Scitex Iris, Imation Rainbow, Kodak Approval, DuPont Digital Cromalin.

• The Lancet cannot accept responsibility for colour reproduction if one of the above colour proofs is not supplied.

mechanical data (all sizes in mm)

size depth width

type area

full page 260 186

double page spread 260 400

trim marks

whole page 282 210

double page spread 282 420

bleed

whole page 292 220

double page spread 292 430

Advertising copy must be supplied digitally to the specifications below.

Neurology

contact

For further information, bookings and to send artwork, please contact:

Martin Sibson

Tel +44 (0) 20 7424 4963 Fax +44 (0) 20 7424 4433 Email m.sibson@elsevier.com

The Lancet Infectious Diseases provides ID specialists with all the information that they need in a clear, concise and readable format.

Each month The Lancet Infectious Diseases reviews the most recent research, highlighting those advances with the greatest and most immediate impact on clinical practice. The Lancet’s global reporting capabilities ensures that The Lancet Infectious Diseases provides the most important and current international news from this vast specialty. .

For our advertisers, this perfect-bound, high-profile journal provides an excellent platform from which to advertise. In print and online The Lancet Infectious Diseases provides you, our advertisers, with a first class media solution which rivals anything available in medical publishing. The Lancet Infectious Diseases is a must-read for ID specialists worldwide.

The WebsiteCombining print advertising with electronic advertising opportunities on The Lancet Infectious Diseases website provides advertisers with access to a vast new audience. The Lancet Infectious Diseases website contains the latest table of contents, abstracts, accepted papers, instructions for authors and more: www.thelancet.com/journals/laninf

display advertising rates

frequency cost

double page spread x1 month £2,005

x3 month £1,856

x6 month £1,790

x12 month £1,485

full page four colour x1 month £1,432

x3 month £1,326

x6 month £1,220

x12 month £1,061

half page four colour x1 month £902

x3 month £835

x6 month £770

x12 month £669

special positions

outside back cover +50%

inside front cover +25%

inside back cover +25%

first right-hand page +20%

first double-page spread +20%

discounts

agency discount 10%

CIRCULaTION

Worldwide – 1,650 BPA DEC 2007

Split runs available on request

The Lancet Infectious Diseases is published

monthly.

All bookings are subject to The Lancet conditions of acceptance.

why advertise in the lancet infectious diseases?

Infectious Diseases

display advertising specifications

digital specifications

• Our preferred method of supply is as a PDF created using Acrobat Distiller Version 5.0.

• PDF files to be supplied as composite CMYK.

• Files must be supplied as single pages.

• Pages must be created to include bleed when required.

• Crop marks must be outside the bleed area. A 3mm offset is recommended.

• Files must contain all images in high-resolution, CMYK format and have all fonts embedded.

flightchecking

• All files must be run through an agreed flight-checking application before transmission, to ensure file and colour integrity. (The flightchecker must ensure the following: Acrobat 3.0 compatibility. Image resolution 300 dpi (min). All fonts embedded. Colour is CMYK).

• Content of digital files must be verified before transmission and all relevant graphics and fonts must be included. The file content remains the responsibility of the sender.

supplying files

• If supplying files on disc, please use industry standard CD-ROM. Media must be write - protected and contain only the file required for each advertisement.

• If a disc is being supplied it should be clearly labelled with identification information indicating client, headline, journal, issue and originator’s details.

• Files may be transmitted via ISDN, with prior arrangement: +44 (0)20 7831 0389.

• An email confirming the sending of any digital advert should be sent prior to transmission and should contain the identification information as specified.

hard copy proofs

• All digital files submitted must be accompanied by a proof. We require 100% of final size, customer approved colour contract proofs.

• Acceptable proofs are: Fuji First Proof, Scitex Iris, Imation Rainbow, Kodak Approval, DuPont Digital Cromalin.

• The Lancet cannot accept responsibility for colour reproduction if one of the above colour proofs is not supplied.

mechanical data (all sizes in mm)

size depth width

type area

full page 260 186

double page spread 260 400

trim marks

whole page 282 210

double page spread 282 420

bleed

whole page 292 220

double page spread 292 430

Advertising copy must be supplied digitally to the specifications below.

Infectious Diseases

contact

For further information, bookings and to send artwork, please contact:

Martin Sibson

Tel +44 (0) 20 7424 4963 Fax +44 (0) 20 7424 4433 Email m.sibson@elsevier.com

The aim of The Lancet Oncology is to publish interesting and informative research on any topic connected with oncology. The journal’s great reputation and high profile allowed it to extend into the field of primary research from May 2005.

Published monthly The Lancet Oncology provides oncology specialists with insightful editorial comment and opinion pieces from influential figures. The Lancet Oncology’s excellent reputation ensures that we can afford to publish only the best reviews and research on topics spanning all oncology related fields. We are therefore viewed as a must-read journal by clinicians, laboratory scientists and policy makers who value the far-reaching content to help guide their decision making.

Advertising in The Lancet Oncology will ensure that your message reaches around 4,500 respected oncology professionals including clinicians specialising in chemotherapy, radiotherapy and surgery, care givers and students.

For our advertisers, this perfect-bound, full colour journal provides the ideal platform to advertise your oncology career opportunities and services to a targeted audience of around 4,500 oncologists worldwide.

The WebsiteCombining print advertising with electronic advertising opportunities on The Lancet Oncology website provides advertisers with access to a vast new audience. The website also contains the latest table of contents, abstracts, accepted papers, instructions for authors and more: www.thelancet.com/journals/lanonc

display advertising rates

frequency cost

double page spread x1 month £2,920

four colour x3 month £2,844

x6 month £2,775

x12 month £2,699

full page four colour x1 month £1,839

x3 month £1,763

x6 month £1,693

x12 month £1,617

full page mono pi only £624

half page mono pi only £364

UK only £1,275

special positions

outside back cover +50%

inside front cover +25%

inside back cover +10%

first right-hand page +20%

discounts

agency discount 10%

split-runs

available for advertisers; UK/Europe/USA/

ROW

circulation

WORLDWIDE – 1691 BPa Dec 2007

The Lancet Oncology is published monthly.

All bookings are subject to The Lancet conditions of acceptance.

why advertise in the lancet oncology?

Oncology

display advertising specifications

digital specifications

• Our preferred method of supply is as a PDF created using Acrobat Distiller Version 5.0.

• PDF files to be supplied as composite CMYK.

• Files must be supplied as single pages.

• Pages must be created to include bleed when required.

• Crop marks must be outside the bleed area. A 3mm offset is recommended.

• Files must contain all images in high resolution,CMYK format and have all fonts embedded.

flightchecking

• All files must be run through an agreed flightchecking application before transmission, to ensure file and colour integrity. (The flightchecker must ensure the following: Acrobat 3.0 compatibility. Image resolution 300 dpi (min). All fonts embedded. Colour is CMYK).

• Content of digital files must be verified before transmission and all relevant graphics and fonts must be included. The file content remains the responsibility of the sender.

supplying files

• If supplying files on disc, please use industry standard CD-ROM. Media must be write -protected and contain only the file required for each advertisement.

• If a disc is being supplied it should be clearly labelled with identification information indicating client, headline, journal, issue and originator’s details.

• Files may be transmitted via ISDN, with prior arrangement: +44 (0)20 7831 0389.

• An email confirming the sending of any digital advert should be sent prior to transmission and should contain the identification information as specified.

hard copy proofs

• All digital files submitted must be accompanied by a proof. We require 100% of final size, customer approved colour contract proofs.

• Acceptable proofs are: Fuji First Proof, Scitex Iris, Imation Rainbow, Kodak Approval, DuPont Digital Cromalin.

• The Lancet cannot accept responsibility for colour reproduction if one of the above colour proofs is not supplied.

mechanical data (all sizes in mm)

size depth width

type area

full page 260 186

double page spread 260 400

trim marks

whole page 282 210

double page spread 282 420

bleed

whole page 292 220

double page spread 292 430

Advertising copy must be supplied digitally to the specifications below.

contact

For further information, bookings and to send artwork, please contact:

Sarah Cahill

Tel +44 (0) 207 424 4538 Fax +44 (0)207 424 4538 Email s.cahill@elsevier.com

Oncology